The US FDA has informed healthcare professionals that Baxter has revised the Warnings section of the labelling for heparin sodium injection

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1568, 2006-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The US FDA has informed healthcare professionals that Baxter has revised the Warnings section of the labelling for heparin sodium injection

By  

Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Jones Pharma Incorporated has issued a `Dear Healthcare Professional' letter advising of changes to the US labelling of Levoxyl [levothyroxine sodium].

By  

Reactions Weekly, Vol. 1, Iss. 1023, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The US FDA has approved acetadote [acetylcysteine] labelling updates

By  

Reactions Weekly, Vol. 1, Iss. 1093, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

US FDA to enhance warnings on antidepressant labelling

By  

Reactions Weekly, Vol. 1, Iss. 1020, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The US FDA has issued a Talk Paper advising of changes to the US Strattera [atomoxetine] labelling

By  

Reactions Weekly, Vol. 1, Iss. 1033, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite